Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.

Authors

J N Katz
S R Smith
J E Collins
D H Solomon
J M Jordan
D J Hunter
L G Suter
E Yelin
A D Paltiel
E Losina

Document Type

Journal Article

Publication Date

3-1-2016

Journal

Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society

Volume

24

Issue

3

Inclusive Pages

409-18

DOI

10.1016/j.joca.2015.10.006

Keywords

Aged; Aged, 80 and over; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Comorbidity; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Health Services Research; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Nonprescription Drugs; Osteoarthritis, Knee; Pain; Pain Measurement; Proton Pump Inhibitors; Quality-Adjusted Life Years; Sensitivity and Specificity; Tramadol; Treatment Outcome; United States

APA Citation

Katz, J., Smith, S., Collins, J., Solomon, D., Jordan, J., Hunter, D., Suter, L., Yelin, E., Paltiel, A., & Losina, E. (2016). Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society, 24 (3). http://dx.doi.org/10.1016/j.joca.2015.10.006

Peer Reviewed

1